Developing 3D-printed surgical guides for cardiovascular surgeries

A research team led by Ida Anna Cappello of the Heart Rhythm Management Centre of the University Hospital Brussels (VUB) has made significant strides in the field of biomedical engineering by developing innovative 3D printed surgical guides for cardiovascular procedures. The team’s research, conducted in close collaboration with cardiologists and cardiac surgeons, holds the potential to revolutionize surgical accuracy in complex heart surgeries.
Read More

Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%

WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer today announced the submission of a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for KERENDIA® (finerenone) for the treatment of patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ≥40%. The submission is based on positive results from the Phase III FINEARTS-HF trial that showed finerenone achieved a statistically significant reduction of the composite of cardiovascular death and t
Read More

AI platform identifies which patients are likely to benefit most from a cancer clinical trial

A study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of the University of Pennsylvania researchers demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a particular therapy being tested in a clinical trial.
Read More

KARL STORZ Acquires Medical Business of Visual Collaboration Software Company T1V

TUTTLINGEN, Germany–(BUSINESS WIRE)–The family-owned MedTech company KARL STORZ is pleased to announce the acquisition of the medical business of T1V, a US-based visual collaboration software company. KARL STORZ has had a longstanding partnership with T1V to build its existing CollaboratOR portfolio. This acquisition marks a significant step for KARL STORZ in shaping integrated hardware and software solutions for digital surgery in global operating rooms, complementing its state-of-the-art en
Read More
Top